Cover Image

Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Stephen M. Brown, Aparna S. Ajjarapu, Divya Ramachandra, Laura Blasco‐Pérez, Mar Costa‐Roger, Eduardo F. Tizzano, Charlotte J. Sumner, Katherine D. Mathews
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Annals of Clinical and Translational Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preemptive dual therapy for children at risk for infantile‐onset spinal muscular atrophy
by: Susan E. Matesanz, et al.
Published: (2024)

Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
by: Delia Gagliardi, et al.
Published: (2024)

Cortical atrophy patterns in myelin oligodendrocyte glycoprotein antibody‐associated disease
by: Ruth Schneider, et al.
Published: (2024)

Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis
by: Ahmed Bayoumi, et al.
Published: (2025)

Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report
by: Penghao Liu, et al.
Published: (2024)

Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy
by: Shruthi Mohan, et al.
Published: (2024)

Asymptomatic spinal lesions in patients with AQP4‐IgG‐positive NMOSD: A real‐world cohort study
by: Shugang Cao, et al.
Published: (2024)

Remote neurodegeneration in the lumbosacral cord one month after spinal cord injury: a cross‐sectional MRI study
by: Silvan Büeler, et al.
Published: (2025)

Acoustic Measures Capture Speech Dysfunction in Spinocerebellar Ataxia
by: Zena Fadel, et al.
Published: (2025)

Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms
by: Charlotte Zejlon, et al.
Published: (2024)

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy
by: Eda G. Kabak, et al.
Published: (2026)

The clinical relevance of MOG antibody testing in cerebrospinal fluid
by: Molly Reynolds, et al.
Published: (2024)

Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data
by: Marta Karas, et al.
Published: (2024)

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
by: David Ledingham, et al.
Published: (2025)

Psoriasis and dementia: A population‐based matched cohort study of adults in England
by: Julian Matthewman, et al.
Published: (2025)

Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study
by: Stephanie M. Hunn, et al.
Published: (2025)

Remaining Burden of Spinal Muscular Atrophy Among Treated Patients: A Survey of Patients and Caregivers
by: Julie A. Parsons, et al.
Published: (2025)

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review
by: Amin Mehrabian, et al.
Published: (2025)

Emergent responsive neurostimulation in pediatric super‐refractory epilepsia partialis continua
by: Peter N. Hadar, et al.
Published: (2024)

Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival
by: Stephen A. Goutman, et al.
Published: (2025)

EEG Response to Sedation Interruption Complements Behavioral Assessment After Severe Brain Injury
by: Charlotte Maschke, et al.
Published: (2025)

Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis
by: Lisa Eunyoung Lee, et al.
Published: (2025)

An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis
by: Ermelinda De Meo, et al.
Published: (2025)

BCS1L‐Associated Disease: 5′‐UTR Variant Shifts the Phenotype Towards Axonal Neuropathy
by: Rotem Orbach, et al.
Published: (2025)

Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy
by: Justina Dargvainiene, et al.
Published: (2024)

A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
by: Natalia E. Owen, et al.
Published: (2025)

Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care
by: Vineet Punia, et al.
Published: (2025)

Iatrogenic cerebral amyloid angiopathy and Alzheimer's disease co‐pathology
by: Francisco Hernández‐Fernández, et al.
Published: (2024)

Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
by: Júlia Sala‐Coromina, et al.
Published: (2026)

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing
by: Mirja Thomsen, et al.
Published: (2025)

Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone
by: Rhett G. Marchant, et al.
Published: (2024)

Clinical characterization of Collagen XII‐related disease caused by biallelic COL12A1 variants
by: Riley M. McCarty, et al.
Published: (2025)

Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features
by: Laura Llansó, et al.
Published: (2025)

Spatiotemporal characteristics of neurophysiological changes in patients with four‐repeat tauopathies
by: Niyatee Samudra, et al.
Published: (2024)

FGF14 GAA Intronic Expansion in Unsolved Adult‐Onset Ataxia in the Care4Rare Canada Consortium
by: Alexanne Cuillerier, et al.
Published: (2025)

Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers
by: Taru M. Flagan, et al.
Published: (2025)

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy
by: Daniel Weintraub, et al.
Published: (2026)

Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles
by: Apostolos Manolopoulos, et al.
Published: (2025)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
by: Lea Gerischer, et al.
Published: (2025)

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels
by: Ricardo Gonzalo, et al.
Published: (2024)